Co-Altria: Adults: One tablet containing Montelukast 10 mg plus Levocetirizine 5 mg once daily. Or as prescribed by the physician.
Elderly: Dosages in the elderly should be adjusted in accordance with their renal function (see Patients with Renal Impairment as follows).
Patients with Renal Impairment: In adults and children 12 years of age and older with: Mild renal impairment (ClCr 50-80 mL/min): one tablet containing Montelukast 10 mg plus Levocetirizine 2.5 mg once daily.
Moderate renal impairment (ClCr 30-50 mL/min): one tablet containing Montelukast 10 mg plus Levocetirizine 2.5 mg once daily, every other day.
Patients with hepatic disease: No dosage adjustment is needed in patients solely with mild to moderate hepatic impairment. Usage is not recommended in patients with severe hepatic impairment.
Adolescents: Children aged 15+: one tablet containing 10 mg Montelukast and Levocetirizine 5 mg once daily.
Or as prescribed by the physician.
Co-Altria Ped: Patients with hepatic disease: No dosage adjustment is needed in patients solely with mild to moderate hepatic impairment. Usage is not recommended in patients with severe hepatic impairment.
Children and Adolescents: Children aged 6-14: one chewable tablet containing 5 mg Montelukast and 2.5 mg Levocetirizine or 5 mg Montelukast and 5 mg Levocetirizine once daily Or as prescribed by the physician.
